These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical study on rebleeding of cerebral anuerysms--with special references to the warning signs of rebleeding and antifibrinolytic treatment during waiting time for surgery (author's transl)].
    Author: Tamaki N, Kusunoki T, Oi S, Taomoto K, Matsumoto S.
    Journal: No Shinkei Geka; 1975 Aug; 3(8):647-54. PubMed ID: 1238945.
    Abstract:
    The warning signs of rebleeding in the ruptured cerebral aneurysms, and the effect of antifibrinolytic treatment on the prevention of rebleeding from the ruptured aneurysms were studied and evaluated satistically by analysing the 62 single ruptured aneurysms. The incidennce of rebleeding during waiting time for surgery was higher in the following factors, i.e., the older patients, the Grade 2, the higher blood pressure, the larger aneurysms, the anterior-communicating aneurysms, the vasospasm. The critical time for rerupture was within three days after admission and within seven days after last bleeding. The anti-edema treatment and the sedation treatment have no effect upon the rebleeding. There was no difference in incidence of rebleeding among the sex and the frequency of bleeding before admission. The operative mortality of the reruptured patients during waiting time for surgery was very high. The antifibrinolytic treatment definitely lessened the incidence of rebleeding of the ruptured aneurysms during waiting time for surgery, and there were no noticeable complications following this treatment. This treatment is of value in the prevention of rebleeding from ruptured cerebral aneurysms during waiting time for surgery.
    [Abstract] [Full Text] [Related] [New Search]